National Association of Medicaid Directors Urges Lawmakers To Curb Costs of Specialty Rx Drugs

The National Association of Medicaid Directors in a letter sent Tuesday urged lawmakers on several congressional committees to help curb the costs of specialty drugs for conditions such as hepatitis C and cancer. NAMD wrote in the letter that Sovaldi -- a hepatitis C drug that costs $84,000 for one course of treatment -- "is just the first of many such exceptionally high-cost 'curative' specialty drugs."

• "States Ask Congress To Intervene on Drug Prices" (AP/U-T San Diego, 10/28).